Menu
Log in


Member Log In


News from our community

<< First  < Prev   1   2   3   4   5   ...   Next >  Last >> 
  • 16 Feb 2024 10:04 AM | Anonymous member (Administrator)

     Acclinate Celebrates Victory in the 3rd Annual Anthem Awards

    Birmingham, AL, January 30, 2024 – Acclinate, a trailblazer in advancing health equity through inclusive research, proudly announces its achievement as a Winner in the esteemed Diversity, Equity, & Inclusion category of the 3rd Annual Anthem Awards.

    The Anthem Awards, hosted by the International Academy of Digital Arts and Sciences, is a prestigious event bringing together influential figures to honor outstanding achievements in purpose-driven initiatives globally.

    Acclinate's innovative approach, blending predictive analytics technology with empowered community building, has not only supported pharmaceutical companies in actively increasing representation in clinical trials but has also championed inclusivity in broader healthcare initiatives. Serving as a catalyst, Acclinate transforms trust and data into products that better serve communities of color.

    Tiffany Whitlow, Chief Development Officer, and co-founder of Acclinate, expressed her excitement, saying, "From the beginning, we recognized the need to change the perception of healthcare, particularly concerning the care of minority communities. Through various mediums, including video storytelling, we have consistently engaged our audience by shedding light on health narratives often overlooked. This accolade underscores our commitment to fostering diversity and health equity in clinical trials, and we are deeply honored by this recognition of our efforts."

    For more information on Acclinate, please visit www.acclinate.com and connect with us on LinkedIn. To learn more about NOWINCLUDED and join the community built for healthier communities of color, visit www.NOWINCLUDED.com and follow us on Instagram.

    Acclinate Media Contact:

    Ellie Newby, Head of Marketing & Communications

    ellie@acclinate.com                                                                256-435-2800


    Find The Anthem Awards Online:

    ● Website: anthemawards.com

    ● Facebook: facebook.com/anthemawards

    ● Twitter: @anthemawards

    ● Instagram: @anthemawards

    ● LinkedIn: The Anthem Awards

    ● YouTube: wbby.co/anthem-youtube

    About The Anthem Awards:

    Launched in 2021 by The Webby Awards, The Anthem Awards honor purpose-driven work globally across seven core causes, including Diversity; Equity & Inclusion; Education; Art & Culture; Health; Human & Civil Rights; Humanitarian Action & Services; Responsible Technology; and Sustainability, Environment & Climate. Founded in partnership with influential organizations such as the Ad Council, Born This Way Foundation, Feeding America, Glaad, Mozilla, NAACP, NRDC, WWF, and XQ.

    Empowering Healthcare Equity: Celebrating 4 Years of Acclinate's Innovation

  • 7 Dec 2023 10:53 AM | Anonymous member (Administrator)


    Reliant Glycosciences, Supported by the Innovate Alabama Supplemental Grant, Host Events for Patients with IgA Nephropathy Birmingham, AL / December 2023 – In 2022, Reliant Glycosciences, LLC (Reliant) received an Innovate Alabama Supplemental Grant for $247,500. This grant is one of the first of its kind in the state of Alabama and provides support for additional work related to a Phase II Award of a Small Business Innovation Research (SBIR) grant from the National Institutes of Health.

    Reliant focuses on developing diagnostics and prognostic tools for patients with IgA nephropathy (IgAN). IgAN is the most common form of glomerulonephritis in the world and affects more than 150,000 Americans. It is even more prevalent in other countries and regions (Europe, Japan, Singapore, and India). Glomerulonephritis is a form of kidney disease that injures the glomeruli, the filtering units of the kidneys. Several of the Reliant Founders helped to define IgAN as an autoimmune disease: Immune complexes are formed from immunoglobulin A protein lacking some sugars (galactose-deficient IgA) bound by immunoglobulin G antibodies (IgG). These complexes form in the blood and ultimately accumulate in the kidneys causing injury.

    With the help of the Innovate Alabama Supplemental Grant, Reliant has hosted several events for IgAN patients. Each event has enabled Reliant to raise awareness of their assays. Ultimately, Reliant’s assays will improve diagnosis and treatment for IgAN. To organize these events, Reliant partnered with the IgA Nephropathy Foundation. This non-profit organization seeks to improve the lives of patients with IgAN through commitments to research, public education, and patient service. The most recent event in July, called SPARK, allowed Reliant to connect with over 250 patients, caregivers, and family members.

    Reliant has developed two assays for IgAN-specific biomarkers. In June, Reliant announced the launch of “The GalD Assay” for release by the end of 2023 as a research tool for the measurement of blood levels of galactose-deficient IgA1. The second assay measures blood levels of the IgG antibody that binds to galactose-deficient IgA1; it is scheduled for release in 2024.

    With the help of the regional events for IgAN patients, the SBIR Phases I and II, consultations with key opinion leaders in the field, the IgA Nephropathy Foundation, and the Innovate Alabama Supplement Grant Program, Reliant has established their footprint in the Birmingham biotech sector.

    Dr. Matthew Renfrow, Reliant Co-Founder, states, “We are proud to be a true homegrown startup that is having an impact worldwide for patients with IgA nephropathy.”

    To learn more about Innovate Alabama, visit the website at: Innovate Alabama – Helping Innovators Grow Roots

    To learn more about Reliant Glycosciences, visit the website at: Biomarker | Reliant Glycosciences, LLC

    To learn more about the IgA Nephropathy Foundation, visit the website at: IgA Nephropathy Foundation

    Written by: Tatum Street, MBA

  • 27 Nov 2023 3:26 PM | Anonymous member (Administrator)

    Innovate Alabama awards $9.3 million to the inaugural designees of the Innovate Alabama Network

    BIRMINGHAM, AL (October 26, 2023) – Innovate Alabama has announced the inaugural designees of the Innovate Alabama Network, a comprehensive resource to connect communities, nonprofits and higher education institutions across Alabama fostering innovation in their local footprint. Fifty-one designees in 17 Alabama counties make up the group, receiving $9.3 million in supporting funds from Innovate Alabama.

    “The Innovate Alabama Network is a major step forward to growing the entrepreneurial and innovation ecosystem in Alabama,” said Innovate Alabama CEO Cynthia Crutchfield. “By providing funding and resources to our local communities, nonprofits and higher education institutions, we are developing a statewide network for innovation programming and catalyzing entrepreneurship in all of our communities, both rural and urban.”

    By investing in these organizations who are shaping the state’s entrepreneurial ecosystem, Innovate Alabama is driving innovation-related activities, encouraging collaboration across the state and providing vital seed funding to propel innovation forward at the community and regional level. In total, 30 nonprofit entities, 11 communities and municipalities and 10 colleges and universities received an Innovate Alabama Network Designation.

    “I’m encouraged and energized to see the overwhelming response to the Innovate Alabama Network,” said Innovate Alabama Board Chairman and Alabama State Director of Finance Bill Poole. “We have a diverse ecosystem for innovation in Alabama, so to bring all of these partners together in one place to partner and collaborate together on moving our state forward is a move in the right direction for Alabama.”

    Applications for the second round of the Innovate Alabama Network are now open. Any interested Alabama community, nonprofit or higher education institution can apply by 5 p.m. CT on Friday, January 5, 2024. Innovate Alabama will host a series of informational webinars and office hours through the end of the year for organizations that want to learn more about the program. To register for these sessions, visit this link.

    Program guidelines have evolved since the Innovate Alabama Network was initially launched. For important key program updates and to apply to the second round of the Innovate Alabama Network, visit innovatealabama.org/innovate-alabama-network.

    Designees from the first round of the Innovate Alabama Network include the following communities, nonprofits and higher education institutions:

    Communities:

    • City of Auburn
    • City of Bessemer
    • City of Dothan
    • City of Henagar
    • City of Hoover
    • City of Marion
    • City of Mobile
    • City of Pinson
    • City of Talladega
    • Shelby County
    • Town of Pike Road

    Nonprofit entities:

    • Alabama Artificial Intelligence Center of Excellence
    • Alabama Trails Foundation
    • Baldwin County Community and Economic Development Foundation
    • BioAlabama
    • Birmingham Bound
    • Birmingham Business Alliance
    • Bronze Valley Foundation
    • Cordova Economic Industrial Development Authority
    • Ed Farm
    • Economic Development Partnership of Alabama
    • Hardware Park
    • HBCU Cares
    • Higher Education Partnership
    • Innovation Depot
    • Innovation Portal
    • Main Street Marion
    • McWane Science Center
    • Montgomery Tech Lab
    • Prosper Foundation
    • QIE Foundation
    • REV Birmingham
    • Singing River Trail
    • Southern Research
    • Teach2Lead
    • The Alabama Collective
    • The Arc of Madison County
    • The E-Center
    • The Overton Project
    • United Way of Southwest Alabama
    • Venture for America

    Higher Education Institutions:

    • Alabama A&M University
    • Alabama State University
    • Auburn Lowder Center for Family and Entrepreneurship
    • Drake State Community and Technical College
    • Talladega College
    • Trenholm State University
    • Troy University
    • University of Alabama
    • University of Alabama at Birmingham
    • University of South Alabama

    ###

    About Innovate Alabama

    Innovate Alabama is Alabama’s first statewide public-private partnership focused on entrepreneurship, technology and innovation with a mission to help innovators grow roots here in Alabama. Innovate Alabama was established to implement the initiatives and recommendations set forth in the Alabama Innovation Commission’s report, including smart policy solutions that will create a more resilient, inclusive and robust economy to remain competitive in a 21st-century world. With founding CEO Cynthia Crutchfield leading the charge, Innovate Alabama is also made up of a board of 11 innovation leaders appointed by Gov. Ivey, collaborating across sectors to advance industries, drive technology and facilitate an environment where innovation and entrepreneurship thrive. Learn more about Innovate Alabama at www.innovatealabama.org.


  • 16 Nov 2022 10:56 AM | Anonymous member

    November 10, 2022 - TIME revealed its annual list of the Best Inventions, which features 200 extraordinary innovations changing our lives.

    We are honored to have GRAIL’s Galleri® test named among the top inventions of 2022. The Galleri test is a multi-cancer early detection (MCED) test that can detect a shared cancer signal across more than 50 types of cancer1 through a simple blood draw.

    Using next-generation genomic sequencing and machine-learning technologies, the Galleri test detects a signal associated with cancer and includes one or two predictions of where in the body the cancer signal originated.

    “I am thrilled to see the Galleri test included in TIME’s list of best inventions of 2022,” said Bob Ragusa, chief executive officer at GRAIL. “We believe strongly in the importance of early cancer detection and the impact it can make on patients’ lives. This test is a promising new tool in our fight against cancer.”

    To compile the list, TIME solicited nominations from TIME’s editors and correspondents around the world, and through an online application process, paying special attention to growing fields—such as the electric vehicle industry, medical care, and the metaverse. TIME then evaluated each contender on a number of key factors, including originality, efficacy, ambition, and impact.

    Of the new list, TIME’s editors write: “The result is a list of 200 groundbreaking inventions (and 50 special mention inventions)—including life-mapping artificial intelligence, diamonds made from excess carbon in the air, and the most powerful telescope ever—that are changing how we live, work, play, and think about what’s possible.”

    See full list HERE.

  • 3 Oct 2022 8:43 AM | Anonymous member

    Dr. Milton Harris, Serina Therapeutics Board Chairman and HudsonAlpha Board Member, was awarded the Per-Åke Albertsson Award for his life-long work in Bio-partitioning and Purification of Aqueous Polymer two-phase systems. Dr. Harris will receive the award at BPP 2022 in Aveiro, Portugal at the end of September. 

    Dr. Per-Åke Albertsson was a Swedish Biochemist, Educator and a Member of the Royal Swedish Academy of Sciences. In his memory, this award is given to exemplary scientists who have contributed in the field of separation sciences.  

    Dr. Milton Harris founded Shearwater Polymers, Inc. in 1992 to advance polyethylene glycol “PEG” technology.  The company later became Nektar Therapeutics. Dr. Harris co-founded Serina Therapeutics in 2006 and joined the Board of the HudsonAlpha Institute for Biotechnology at the same time. Dr. Harris is also the recipient of the Nagai Innovation Award (2005, Controlled Release Society) and a member of the Swedish Academy of Engineering Sciences.

  • 14 Sep 2022 11:24 AM | Anonymous member

    BIO Alabama CEO Headed to Oklahoma

    September 14, 2022

    BIO Alabama CEO Rachel Lane, PhD, RD steps down from the association at the end of September to transition her efforts to the Tulsa Innovation Labs Canopy Virtual HealthTech program in Tulsa, Oklahoma.

    Under Dr. Lane’s leadership, BIO Alabama and the state’s bioscience industry grew significantly, marked by the following key accomplishments:

    • Annual Conference | This in-person, two-day meeting gathered over 200 statewide industry partners and featured leaders and speakers from across the US.
    • Inaugural RALLY | This reverse-pitch event was supported by the AL Department of Commerce and connected local and national industry companies with Alabama academic institutions for collaboration.
    • Workforce Development | This initiative in collaboration with the AL Department of Commerce and AIDT charts a path for upscaling Alabama’s bioscience workforce.
    • Small Business Innovation Research (SBIR)/Small Business Tech Transfer Research (STTR) Award Workshops | The workshops are sponsored by the Innovation Corporation and connect innovators with federal agencies and information about nondilutive funding.
    • Platforms | BIO Alabama’s advocacy on behalf of Alabama bioscience companies create opportunities for innovators to be showcased on regional, national, and international stages.

    BIO Alabama held their first in-person conference in six years in April 2022.

    “Dr. Lane applied her vision and knowledge to take our industry to new, innovative levels,” said Chairperson Kacee Sims, PhD, director of marketing and technical services at Avanti Polar Lipids, Inc. “Losing her leadership is a disappointment, but I know she will continue to be an ambassador for us beyond our state’s lines.”

    Dr. Lane expressed gratitude to the Alabama bioscience and innovation community, stating “We have made significant strides toward our vision for the industry, thanks to the collaborative, welcoming spirit of this community. There is still work to be done, and it must be done together. The Alabama spirit that fueled our progress these past two years will continue to propel momentum forward.”

    Dr. Lane presents at the EDAA 2022 winter conference with panelists Vince Perez (AL Department of Commerce), Amy Sturdivant (58, Inc), and Blair King (Alabama Power).

    The BIO Alabama executive committee is strategizing a transition plan to ensure the continuation of Alabama’s forward progress in the industry.

    “BIO AL is a critical catalyst for our state’s industry,” stated Bill Dean, executive director of the Auburn Research and Technology Foundation and member of BIO AL’s executive committee. “We are evaluating Dr. Lane’s thoughtful transition plan and are committed to continuing the momentum we have gained over the last two years.”

    BIO Alabama was founded in 1998 by industry leaders from across the state and is the state affiliate for BIO International. Bioscience companies in Alabama feed, fuel, and heal the world. BIO Alabama is committed to developing and fortifying the ecosystem that promotes the success of these companies by ensuring these companies have the intellectual property, people, space, capital, and business environment to complete their mission.

    Learn more about BIO Alabama at bioalabama.com.

  • 7 Sep 2022 11:41 AM | Anonymous member

    Birmingham, AL / September 2022 – Reliant Glycosciences, LLC (Reliant) is pleased to announce that the company has been awarded an Innovate Alabama Supplemental Grant for $247,500. This grant is one of the first of its kind in the state of Alabama and will support the company’s National Institutes of Health Small Business Innovation Research (SBIR) Phase II Award.

    As stated in a press release by Gov. Kay Ivey, “The Innovate Alabama Supplemental Grant Program is the latest way our state is creating an attractive business environment for pioneering ideas that will change our world. Alabamians have the grit, determination, and creativity to make these ideas a reality, and with Innovate Alabama’s supplemental funding, these small businesses will take their ideas from concept to commercialization.”

    With a SBIR Phase II Award, Reliant was eligible to apply for matching funds to their award.

    Dr. Kathy Nugent, the executive director of the UAB Bill L. Harbert Institute for Innovation and Entrepreneurship, commented in an UAB News Article, The Innovate Alabama Supplemental Grant Program is a fantastic opportunity for UAB-based start-ups who have already received SBIR and STTR funding to continue to develop their innovative technologies. These technologies have already passed muster with scientific experts, making them strong investments for state funding.

    Reliant was formed with the mission to develop assays for biomarkers of IgA nephropathy with the diagnostic and/or prognostic value that will enable the development and monitoring of future disease-specific therapies. IgA nephropathy is a kidney disease that often leads to kidney failure.

    Reliant Co-Founder, Dr. Matthew Renfrow stated “This is a great opportunity for us and the state of Alabama. We are a local spin-off from UAB and we are so grateful to Governor Kay Ivey, Chairman Bill Poole, and all of the members of the Alabama Innovation Corporation Board of Directors for the vision and foresight of a program like Innovate Alabama to promote and support a small business that has the potential to have a big impact in the biotechnology sector.”

    https://www.reliantglycosciences.com/

    https://innovatealabama.org/

    Written by: Tatum Street, MBA

  • 25 Aug 2022 1:20 PM | Anonymous member

    Serina Therapeutics announced that it was recently awarded $250,000 by the State of Alabama’s Innovate Alabama Supplemental Grant.

    The funding helps support the development of SER-227, a medication that can be administered in a hospital room by a physician to provide immediate and prolonged pain relief over a period of 3-5 days. The prolonged nature of the medicine is to prevent the need to use potentially addictive opioids such as morphine in the immediate post-op period. 

    Dr. Tacey Viegas, Serina’s chief operating officer and project director, said the grant will be used to complete the product development and pre-clinical studies required to support the initiation of clinical trials.

    “We’re grateful to Governor Kay Ivey, Chairman Bill Poole and all the members of the Alabama Innovation Corporation Board of Directors”, Viegas said. “The Innovate Alabama Supplemental Grant helps small businesses like us take our ideas from concept to a path for commercialization and ultimately helps improve the quality of life here in Alabama, and we hope, around the world.”

    Serina is a Huntsville-based pharmaceutical research and development company that has developed a proprietary drug delivery technology platform. The new grant supplements another grant the company received in 2019 from the National Institutes of Health (NIH) and the National Institute of Neurological Disorders and Stroke (NINDS) through the Helping to End Addiction Long-Term (HEAL) program. 

  • 14 Jul 2022 7:53 AM | Anonymous member

    Higher Orbits will launch its final event of the BRPH Series, Go For Launch! Alabamanext week running July 20-22, thanks to stellar support from their Series Sponsor.

    The hands-on flagship program of Higher Orbits spotlights the wonders of spaceflight and space exploration to provide students across the country the opportunity to develop and strengthen their skills in STEM, teamwork, communication, research design, and leadership. While focusing on spaceflight, Go For Launch! students work alongside a featured astronaut at each event to learn and develop important skills that can be applied in any professional field.

    Read the full article HERE.

  • 5 Jul 2022 3:00 PM | Anonymous member

    Eurofins Discovery acquired DiscoveryBioMed for its expertise in leveraging primary and immortalized human diseased and normal cells to develop novel, customized bioassays supporting clients from HTS to lead optimization. DiscoveryBioMed achieves this through its focus on biologically relevant cellular models for the renal, skin, taste, ophthalmic, liver, respiratory, oncology, and other therapeutic areas. The addition of DiscoveryBioMed supports Eurofins Discovery's strategy to have the most complete, highest quality portfolio of drug discovery services and products, and further strengthens its ability to support translational biology for drug discovery research and development.

    Read full article here.

<< First  < Prev   1   2   3   4   5   ...   Next >  Last >> 

Connecting the Bioscience Ecosystem in Alabama

BIO Alabama
P.O. Box 583
Arab, AL 35016


administrator@bioalabama.com

© BIO Alabama

Powered by Wild Apricot Membership Software